Anti-inflammatory treatments for stroke: from bench to bedside

被引:69
|
作者
Drieu, Antoine [1 ]
Levard, Damien [1 ]
Vivien, Denis [1 ,2 ]
Rubio, Marina [1 ]
机构
[1] Normandy Univ, Pathophysiol & Imaging Neurol Disorders, Blvd Henri Becquerel BP 5229, F-14000 Caen, France
[2] CHU Caen, Imaging Neurol Disorders, Caen, France
关键词
clinical trial; immunomodulatory drugs; inflammation; stroke models; translation; ACUTE ISCHEMIC-STROKE; REGULATORY T-CELLS; FOCAL CEREBRAL-ISCHEMIA; SPINAL-CORD-INJURY; INTERLEUKIN-1 RECEPTOR ANTAGONIST; IMMUNE MODULATOR FINGOLIMOD; SENSITIVE MOLECULAR MRI; CENTRAL-NERVOUS-SYSTEM; REDUCES BRAIN-DAMAGE; THROMBOEMBOLIC STROKE;
D O I
10.1177/1756286418789854
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
So far, intravenous tissue-type plasminogen activator (tPA) and mechanical removal of arterial blood clot (thrombectomy) are the only available treatments for acute ischemic stroke. However, the short therapeutic window and the lack of specialized stroke unit care make the overall availability of both treatments limited. Additional agents to combine with tPA administration or thrombectomy to enhance efficacy and improve outcomes associated with stroke are needed. Stroke-induced inflammatory processes are a response to the tissue damage due to the absence of blood supply but have been proposed also as key contributors to all the stages of the ischemic stroke pathophysiology. Despite promising results in experimental studies, inflammation-modulating treatments have not yet been translated successfully into the clinical setting. This review will (a) describe the timing of the stroke immune pathophysiology; (b) detail the immune responses to stroke sift-through cell type; and (c) discuss the pitfalls on the translation from experimental studies to clinical trials testing the therapeutic pertinence of immune modulators.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Sphingosine-1-Phosphate Signaling in Ischemic Stroke: From Bench to Bedside and Beyond
    Zhang, Shuo-Qi
    Xiao, Jun
    Chen, Man
    Zhou, Luo-Qi
    Shang, Ke
    Qin, Chuan
    Tian, Dai-Shi
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2021, 15
  • [42] Adipose Tissue-derived Stem Cells in Stroke Treatment: From Bench to Bedside
    Gutierrez-Fernandez, Maria
    Rodriguez-Frutos, Berta
    Otero-Ortega, Laura
    Ramos-Cejudo, Jaime
    Fuentes, Blanca
    Diez-Tejedor, Exuperio
    DISCOVERY MEDICINE, 2013, 16 (86) : 37 - 43
  • [43] Phase II anti-inflammatory and immune-modulating drugs for acute ischaemic stroke
    Smith, Craig J.
    Denes, Adam
    Tyrrell, Pippa J.
    Di Napoli, Mario
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2015, 24 (05) : 623 - 643
  • [44] Suppression of dendritic cell functions contributes to the anti-inflammatory action of granulocyte-colony stimulating factor in experimental stroke
    Dietel, Barbara
    Cicha, Iwona
    Kallmuenzer, Bernd
    Tauchi, Miyuki
    Yilmaz, Atilla
    Daniel, Werner G.
    Schwab, Stefan
    Garlichs, Christoph D.
    Kollmar, Rainer
    EXPERIMENTAL NEUROLOGY, 2012, 237 (02) : 379 - 387
  • [45] Monoclonal Antibody-Based Treatments for Neuromyelitis Optica Spectrum Disorders: From Bench to Bedside
    Wenli Zhu
    Yaling Zhang
    Zhen Wang
    Ying Fu
    Yaping Yan
    Neuroscience Bulletin, 2020, 36 : 1213 - 1224
  • [46] Near-infrared laser treatment of acute stroke. From bench to bedside
    Schellinger, P. D.
    Koehrmann, M.
    NERVENARZT, 2012, 83 (08): : 966 - +
  • [47] The immunology of tuberculosis: From bench to bedside
    Dheda, Keertan
    Schwander, Stephan K.
    Zhu, Bingdong
    van Zyl-Smit, Richard N.
    Zhang, Ying
    RESPIROLOGY, 2010, 15 (03) : 433 - 450
  • [48] Monoclonal Antibody-Based Treatments for Neuromyelitis Optica Spectrum Disorders: From Bench to Bedside
    Zhu, Wenli
    Zhang, Yaling
    Wang, Zhen
    Fu, Ying
    Yan, Yaping
    NEUROSCIENCE BULLETIN, 2020, 36 (10) : 1213 - 1224
  • [49] Corticosteroids in sepsis: From bench to bedside?
    Annane, D
    Cavaillon, JM
    SHOCK, 2003, 20 (03): : 197 - 207
  • [50] Editorial: Necroptosis: from bench to bedside
    Bonnet, Marion C.
    Sun, Liming
    FRONTIERS IN IMMUNOLOGY, 2024, 15